11 Best Performing Healthcare Stocks to Buy Now

Page 3 of 10

8. Corcept Therapeutics Incorporated (NASDAQ:CORT)

YTD Performance: 39.37%

Number of Hedge Fund Holders: 29

Corcept Therapeutics Incorporated (NASDAQ:CORT) is a biopharmaceutical company that develops and commercializes therapies that adjust the effects of cortisol, a hormone that regulates various bodily functions. The company’s flagship product, Korlym, is FDA-approved for treating Cushing’s syndrome, a disorder caused by excessive cortisol production. The stock ranks eighth among the best-performing healthcare stocks to invest in.

On May 7, Canaccord Genuity analyst Edward Nash maintained their bullish stance on Corcept Therapeutics Incorporated (NASDAQ:CORT), giving it a Buy rating. The analyst reasoned that while the company experienced a weaker fiscal Q1 2025 due to shipping and packing complications, management is confident about its ability to resolve these issues and support strong performance in the coming quarters.

In fact, the analyst believes that Corcept Therapeutics Incorporated’s (NASDAQ:CORT) current weakness presents an attractive buying opportunity as its Korlym product is expected to see continuous revenue growth and growing demand.

In addition, the company’s expansion into oncology is a promising development, especially in its upcoming NDA filing for relacorilant in platinum-resistant ovarian cancer. According to the analyst, the drug has blockbuster potential following its potential approval, further augmenting Corcept Therapeutics Incorporated’s (NASDAQ:CORT) market opportunities.

Page 3 of 10